Inhibition of fatty acid catabolism augments the efficacy of oxaliplatin-based chemotherapy in gastrointestinal cancers. Wang Y, Lu JH, Wang F, Wang YN, et al. Cancer Lett 2020;473:74-89.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Wang Y, Lu JH, Wang F, Wang YN, et al. Inhibition of fatty acid catabolism augments the efficacy of oxaliplatin-based chemotherapy in gastrointestinal cancers. Cancer Lett 2020;473:74-89.
PMID: 31904482